In this on-demand webinar for general practitioners, hear from a multidisciplinary panel of leading Australian healthcare professionals as they discuss the importance of biosimilar medicines and tips for supporting patient education and confidence
By the end of this course, participants should be able to:
- Outline the clinical development and regulatory processes required prior to approval of biosimilar medicines
- Explain to patients what a biosimilar medicine is, why it is different to a generic medicine, and their therapeutic equivalence to the reference biological product
- Explain how biosimilar medicines contribute to the sustainability of the Australian healthcare system.
This education is a CPD-accredited activity under the RACGP CPD Program for the 2020-22 triennium. This activity is designed to take 1 hour to complete.
Other healthcare professionals can still enrol and complete this course. You will receive a certificate upon completion.